| Name | Last modified | Size | Description | |
|---|---|---|---|---|
| Parent Directory | - | |||
| 230719_SN_LeoPruimbo..> | 2023-07-26 09:20 | 4.3K | ||
| 230719_SN_LeoPruimbo..> | 2023-07-26 09:20 | 32K | ||
| 230719_SN_LeoPruimbo..> | 2023-07-26 09:20 | 28K | ||
| 230719_SN_LeoPruimbo..> | 2023-07-26 09:20 | 35K | ||
| 230719_SN_LeoPruimbo..> | 2023-07-26 09:20 | 66K | ||
| 230719_SN_LeoPruimbo..> | 2023-07-26 09:20 | 68K | ||
| 230719_SN_LeoPruimbo..> | 2023-07-26 09:20 | 54K | ||
| 230719_SN_LeoPruimbo..> | 2023-07-26 09:20 | 62K | ||
| 230719_SN_LeoPruimbo..> | 2023-07-26 09:20 | 7.7K | ||
| 230719_SN_LeoPruimbo..> | 2023-07-26 09:20 | 97K | ||
| 230719_SN_LeoPruimbo..> | 2023-07-26 09:20 | 14K | ||
| 230719_SN_LeoPruimbo..> | 2023-07-26 09:20 | 192K | ||
| 2023-1485-RESPONSE.pdf | 2023-07-21 11:54 | 206K | ||
| Burgess-Wexton-Compo..> | 2023-07-06 12:14 | 632K | ||
| 2023-05-30-FDA-Compo..> | 2023-07-06 12:13 | 32K | ||
